Small World derived index to distinguish Alzheimer's type dementia and healthy subjects.

Fabrizio VecchioFrancesca MiragliaChiara PappaletteraLorenzo NucciAlessia CacciottiPaolo Maria Rossini

Published in: Age and ageing (2024)

These findings suggest that SWcomb index represents an easy-to-perform, low-cost, widely available and non-invasive biomarker for distinguishing between healthy individuals and AD patients.

Keyphrases

low cost
end stage renal disease
newly diagnosed
chronic kidney disease
mild cognitive impairment
prognostic factors
peritoneal dialysis
cognitive impairment
patient reported